CN112007101A - Clove antibacterial liquid - Google Patents
Clove antibacterial liquid Download PDFInfo
- Publication number
- CN112007101A CN112007101A CN202010783671.5A CN202010783671A CN112007101A CN 112007101 A CN112007101 A CN 112007101A CN 202010783671 A CN202010783671 A CN 202010783671A CN 112007101 A CN112007101 A CN 112007101A
- Authority
- CN
- China
- Prior art keywords
- extract
- parts
- clove
- safflower
- rosemary
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/268—Asarum (wild ginger)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/533—Leonurus (motherwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8884—Arisaema, e.g. Jack in the pulpit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a clove antibacterial liquid which is prepared from the following raw materials in parts by volume: 1-3 parts of safflower extract, 1-3 parts of clove extract, 1-3 parts of laurel extract, 1-3 parts of rosemary extract, 1-3 parts of asarum extract, 1-3 parts of arisaema cum bile extract, 1-3 parts of motherwort extract, 1-3 parts of salvia miltiorrhiza extract, 1-3 parts of rhizoma cyperi extract, 1-3 parts of folium artemisiae argyi extract and 1-3 parts of stephanotis extract. According to the clove antibacterial liquid, the safflower extract, the clove extract, the bay extract, the rosemary extract, the asarum extract, the arisaema consanguineum extract, the motherwort extract, the salvia miltiorrhiza extract, the rhizoma cyperi extract, the folium artemisiae argyi extract and the white drug extract are combined, so that the prepared clove antibacterial liquid has an antibacterial effect and an effect of regulating meridians, and further effects of enriching antibacterial products and improving sub-health states are achieved.
Description
Technical Field
The invention relates to the technical field of antibacterial compositions, and particularly relates to clove antibacterial liquid.
Background
Along with the improvement of the public requirement on personal hygiene, the number of sanitary products with bacteriostatic effect on the market is increasing, but related products with bacteriostatic and meridian conditioning functions are not available on the market. In traditional Chinese medicine, meridians are the channels that circulate qi and blood and connect various parts of the body, and the book Huangdi's internal classic records that the twelve main meridians of Fudui belong to the zang-fu organs and are externally connected to the limbs and joints. The unsmooth channels and collaterals lead to the increasing number of sub-health people, so a new product integrating bacteriostasis and regulating channels and collaterals needs to be provided.
Disclosure of Invention
Aiming at the technical problems in the related art, the invention provides clove antibacterial liquid which can overcome the defects in the prior art.
In order to achieve the technical purpose, the technical scheme of the invention is realized as follows:
the clove antibacterial liquid is prepared from the following raw materials in parts by volume: 1-3 parts of safflower extract, 1-3 parts of clove extract, 1-3 parts of laurel extract, 1-3 parts of rosemary extract, 1-3 parts of asarum extract, 1-3 parts of arisaema cum bile extract, 1-3 parts of motherwort extract, 1-3 parts of salvia miltiorrhiza extract, 1-3 parts of rhizoma cyperi extract, 1-3 parts of folium artemisiae argyi extract and 1-3 parts of stephanotis extract.
Preferably, the clove bacteriostatic liquid is prepared from the following raw materials: 2 parts of safflower extract, 3 parts of clove extract, 1 part of laurel extract, 1 part of rosemary extract, 2 parts of asarum extract, 2 parts of rhizoma arisaematis preparata extract, 1 part of motherwort extract, 1 part of salvia miltiorrhiza extract, 3 parts of rhizoma cyperi extract, 3 parts of folium artemisiae argyi extract and 3 parts of radix stephaniae tetrandrae extract.
Preferably, the clove extract is obtained by extracting clove with water and/or alcohol under ultrasonic conditions.
Preferably, the safflower extract is obtained by extracting safflower with ethyl acetate.
Preferably, the laurel extract is obtained by extracting laurel with ethanol.
Preferably, the rosemary extract is obtained by extracting rosemary with ethanol.
The safflower extract is pungent and warm, enters heart and liver meridians, promotes blood circulation to remove meridian obstruction, removes blood stasis and relieves pain, and is used for amenorrhea, dysmenorrhea, lochiorrhea, abdominal mass, traumatic injury, sore and ulcer with swelling and pain.
The clove has strong inhibition effect on the mould, can effectively inhibit the growth and the propagation of the mould, inhibits spores from shrinking, and further effectively inhibits the growth of the mould for a long time. The clove extract has obvious bacteriostatic effect and has the characteristics of light color, pure fragrance and the like.
The compendium of materia medica considers that the medicinal value of bay is: for treating various diseases, nourishing spirit and color, the medicines are firstly used for communication, and the medicine is long-term taken, light and not old, has a bright face and is good as children. According to the traditional Chinese medicine, the cinnamomum longepaniculatum (i.e. the fresh, dry and tender cinnamomum cassia tree) has the effects of sweating, relieving the skin surface and the limb wind-cold and warming and dredging the channels and collaterals, and is a good medicine for treating the anemofrigid-damp arthralgia and the joint pain. Cassia bark: cinnamon, pungent, sweet and hot in nature, has the effects of tonifying primordial yang, warming spleen and stomach, removing cold accumulation and promoting blood circulation. The Laurus nobilis extract can be used as antibacterial agent, acaricidal agent, antioxidant and antiaging agent, antiinflammatory agent and whitening agent.
The rosemary extract mainly comprises rosmanol, carnosol and carnosic acid, and a plurality of main components in the rosemary extract have strong antioxidant activity and have obvious effects on preventing grease oxidation and the like.
The asarum has the effects of relieving exterior syndrome and dispelling cold, dispelling wind and relieving pain, dredging orifices, warming lung and transforming fluid, and is used for treating cold, headache, toothache, nasal obstruction and discharge, allergic rhinitis, nasosinusitis, rheumatic arthralgia, phlegm retention and cough and asthma.
The arisaema tuber is bitter and pungent in taste, warm in nature, enters lung, liver and spleen channels, has the functions of eliminating dampness and phlegm, dispelling wind and arresting convulsion, dispersing lumps and dissipating binds, and relieving swelling and pain, is a common clinical product of the arisaema tuber, the prepared arisaema tuber and 3 arisaema cum bile, is toxic, is clinically and externally applied and has good swelling and pain relieving effects.
The motherwort herb is bitter and pungent, is slightly cold, enters liver, pericardium and bladder channels, has the functions of promoting blood circulation to regulate menstruation, inducing diuresis to reduce edema, clearing heat and removing toxicity, and is used for treating irregular menstruation, dysmenorrheal, amenorrhea, continuous lochiorrhea, edema, oliguria, pyocutaneous disease and pyogenic infections.
Salvia miltiorrhiza, which is bitter in taste and slightly cold, enters heart and liver channels, activates blood circulation to dissipate blood stasis, clears meridians to stop pain, clears heart and relieves restlessness, cools blood and eliminates carbuncle, and is used for treating thoracic obstruction, heart pain, abdominal and hypochondriac pain, abdominal mass and mass, heat arthralgia pain, vexation and insomnia, irregular menstruation, dysmenorrheal, amenorrhea and sore and ulcer with swelling and pain.
Rhizoma Cyperi enters liver, spleen and triple energizer channels, has effects of dispersing stagnated liver qi for relieving qi stagnation, regulating qi-flowing for relieving epigastric distention, regulating menstruation and relieving pain, and can be used for treating stagnation of qi due to liver depression, distending pain in chest and hypochondrium, hernia pain, breast pain, qi stagnation in spleen and stomach, abdominal distention and fullness, distention and pain, menoxenia, and amenorrhea and dysmenorrhea.
The folium artemisiae argyi is pungent, bitter and warm, warms the channel to stop bleeding, dispels cold to stop pain; it can be used for external use for eliminating dampness and relieving itching, and can be used for treating hematemesis, epistaxis, metrorrhagia, menorrhagia, fetal leakage, lower abdomen psychroalgia, menoxenia, and infertility due to cold womb; it can be used for treating skin pruritus. Vinegar moxa charcoal can warm meridians and stop bleeding, and is indicated for bleeding due to deficiency-cold.
The white drug has the effects of removing blood stasis, stopping bleeding, promoting blood circulation, relieving pain, detoxifying and reducing swelling, and is used for treating traumatic injury, blood stasis, swelling and pain, hematemesis, hemoptysis, hematochezia, hemorrhoidal bleeding, metrorrhagia and metrostaxis, operative bleeding, pyocutaneous disease and soft tissue pyocutaneous disease, closed fracture, bronchiectasis, phthisis, hemoptysis, ulcer bleeding and skin infectious diseases.
The invention has the beneficial effects that: according to the clove antibacterial liquid, the safflower extract, the clove extract, the bay extract, the rosemary extract, the asarum extract, the arisaema consanguineum extract, the motherwort extract, the salvia miltiorrhiza extract, the rhizoma cyperi extract, the folium artemisiae argyi extract and the white drug extract are combined, so that the prepared clove antibacterial liquid has an antibacterial effect and an effect of regulating meridians, and further effects of enriching antibacterial products and improving sub-health states are achieved.
Detailed Description
The technical solutions in the embodiments of the present invention are clearly and completely described below, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments. All other embodiments that can be derived by one of ordinary skill in the art from the embodiments given herein are intended to be within the scope of the present invention.
Example 1
The clove antibacterial liquid is prepared from the following raw materials: 10mL of safflower extract, 30mL of clove extract, 30mL of laurel extract, 10mL of rosemary extract, 10mL of asarum extract, 10mL of arisaema tuber extract, 10mL of motherwort extract, 10mL of salvia miltiorrhiza extract, 10mL of rhizoma cyperi extract, 10mL of folium artemisiae argyi extract and 10mL of stephanotis extract. Wherein the clove extract is obtained by extracting clove with water and/or alcohol under an ultrasonic condition, the safflower extract is obtained by extracting safflower with ethyl acetate, the bay extract is obtained by extracting bay with ethanol, and the rosemary extract is obtained by extracting rosemary with ethanol.
Example 2
The clove antibacterial liquid is prepared from the following raw materials: 20mL of safflower extract, 30mL of clove extract, 10mL of laurel extract, 10mL of rosemary extract, 20mL of asarum extract, 20mL of arisaema tuber extract, 10mL of motherwort extract, 10mL of salvia extract, 30mL of rhizoma cyperi extract, 30mL of folium artemisiae argyi extract and 30mL of stephanotis extract. Wherein the clove extract is obtained by extracting clove with water and/or alcohol under an ultrasonic condition, the safflower extract is obtained by extracting safflower with ethyl acetate, the bay extract is obtained by extracting bay with ethanol, and the rosemary extract is obtained by extracting rosemary with ethanol.
Example 3
The clove antibacterial liquid is prepared from the following raw materials: 30mL of safflower extract, 10mL of clove extract, 20mL of laurel extract, 30mL of rosemary extract, 30mL of asarum extract, 30mL of arisaema tuber extract, 30mL of motherwort extract, 30mL of salvia miltiorrhiza extract, 30mL of rhizoma cyperi extract, 30mL of folium artemisiae argyi extract and 30mL of stephanotis extract. Wherein the clove extract is obtained by extracting clove with water and/or alcohol under an ultrasonic condition, the safflower extract is obtained by extracting safflower with ethyl acetate, the bay extract is obtained by extracting bay with ethanol, and the rosemary extract is obtained by extracting rosemary with ethanol.
The application method of the clove antibacterial liquid comprises the steps of massaging and kneading the corresponding parts (kneading is forbidden for people with hydrarthrosis in joints), smearing the clove antibacterial liquid under the state that skin is easy to absorb, and then winding and covering the clove antibacterial liquid with a preservative film for 1-2 hours, so that the clove antibacterial liquid has a better effect, and not only can relax the body and relax the tendons and activate the collaterals, but also can smooth and sooth the heart. In addition, the hands should be washed with hand washing liquid and clear water immediately after being worn.
The safflower extract, clove extract, bay extract, rosemary extract, asarum extract, arisaema cum bile extract, motherwort extract, salvia miltiorrhiza extract, cyperus rotundus extract, artemisia leaf extract and stephanotis extract described in examples 1-3 can be commercially available products.
In summary, according to the technical scheme of the invention, the prepared clove antibacterial liquid has the antibacterial effect and the effect of regulating meridians by combining the safflower extract, the clove extract, the laurel extract, the rosemary extract, the asarum extract, the arisaema cum bile extract, the motherwort extract, the salvia miltiorrhiza extract, the rhizoma cyperi extract, the folium artemisiae argyi extract and the white yam extract, so that the effects of enriching antibacterial products and improving the sub-health state are achieved.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents, improvements and the like that fall within the spirit and principle of the present invention are intended to be included therein.
Claims (6)
1. The clove antibacterial liquid is characterized by being prepared from the following raw materials in parts by volume: 1-3 parts of safflower extract, 1-3 parts of clove extract, 1-3 parts of laurel extract, 1-3 parts of rosemary extract, 1-3 parts of asarum extract, 1-3 parts of arisaema cum bile extract, 1-3 parts of motherwort extract, 1-3 parts of salvia miltiorrhiza extract, 1-3 parts of rhizoma cyperi extract, 1-3 parts of folium artemisiae argyi extract and 1-3 parts of stephanotis extract.
2. The clove bacteriostatic liquid according to claim 1, which is prepared from the following raw materials in parts by volume: 2 parts of safflower extract, 3 parts of clove extract, 1 part of laurel extract, 1 part of rosemary extract, 2 parts of asarum extract, 2 parts of rhizoma arisaematis preparata extract, 1 part of motherwort extract, 1 part of salvia miltiorrhiza extract, 3 parts of rhizoma cyperi extract, 3 parts of folium artemisiae argyi extract and 3 parts of radix stephaniae tetrandrae extract.
3. The clove bacteriostatic liquid as claimed in claim 1 or 2, wherein the clove extract is extracted from clove by water and/or alcohol under ultrasonic condition.
4. The clove bacteriostatic solution as claimed in claim 1 or 2, wherein the safflower extract is obtained by extracting safflower with ethyl acetate.
5. The clove bacteriostatic solution according to claim 1 or 2, wherein the laurel extract is obtained by extracting laurel with ethanol.
6. The clove bacteriostatic solution according to claim 1 or 2, wherein the rosemary extract is obtained by extracting rosemary with ethanol.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010783671.5A CN112007101A (en) | 2020-08-06 | 2020-08-06 | Clove antibacterial liquid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010783671.5A CN112007101A (en) | 2020-08-06 | 2020-08-06 | Clove antibacterial liquid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112007101A true CN112007101A (en) | 2020-12-01 |
Family
ID=73498611
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010783671.5A Pending CN112007101A (en) | 2020-08-06 | 2020-08-06 | Clove antibacterial liquid |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112007101A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113208963A (en) * | 2021-05-14 | 2021-08-06 | 广东博禧高新科技有限公司 | Efficient antibacterial hand sanitizer and preparation method thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102727611A (en) * | 2012-07-02 | 2012-10-17 | 北京华夏众芳生物科技有限公司 | Topical Chinese medicinal composition/preparation with antibacterial, antipruritic and repairing effects, and preparation method thereof |
-
2020
- 2020-08-06 CN CN202010783671.5A patent/CN112007101A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102727611A (en) * | 2012-07-02 | 2012-10-17 | 北京华夏众芳生物科技有限公司 | Topical Chinese medicinal composition/preparation with antibacterial, antipruritic and repairing effects, and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 陈超树等: "贵妃浴精抗菌杀虫作用的实验研究", 《中国中医药科技》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113208963A (en) * | 2021-05-14 | 2021-08-06 | 广东博禧高新科技有限公司 | Efficient antibacterial hand sanitizer and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103446001B (en) | Breast beautifying skin and preserving health massage cream and manufacture method thereof | |
| CN107952018A (en) | A kind of Chinese medicine composition of lady's vaginal contraction cleaning anti-inflammatory | |
| CN103341184A (en) | Ultrasonic coupling agent and preparation method thereof | |
| CN103751812A (en) | Ultrasonic couplant and preparation method thereof | |
| CN103860978A (en) | Traditional Chinese medicine preparation for treating bedsore and preparation method thereof | |
| CN103405595B (en) | A kind of Chinese medicine for the treatment of nasal sinusitis | |
| CN110339249B (en) | Traditional Chinese medicine composition for treating hemorrhoids and anal fissure as well as preparation method and application thereof | |
| CN112007101A (en) | Clove antibacterial liquid | |
| CN101164600A (en) | Medicine for treating acne and whelk | |
| CN110664941A (en) | Traditional Chinese medicine health preparation for activating qi and blood | |
| CN102302765B (en) | Herba sarcandrae, rhizoma cibotii, suberect spatholobus stem and muskroot-like semiaquilegia root powder for treating lower extremity varicose veins | |
| CN106421392A (en) | Traditional Chinese medicinal gel for treating bedsore and preparation method of traditional Chinese medicinal gel | |
| CN103223158B (en) | External medicine for treating alopecia | |
| CN107569580B (en) | A topical Chinese medicinal composition for treating hemorrhoid, and its preparation method | |
| CN111658711A (en) | Traditional Chinese medicine formula for treating burns and scalds | |
| CN105267868A (en) | External plaster for treating breast hyperplasia | |
| CN103948709B (en) | Palace, a kind of Uygur medicine heat seal Meikang suppository and preparation method thereof | |
| CN104127765B (en) | Drops for treating skin tinea and preparation method thereof | |
| CN115006473B (en) | Traditional Chinese medicine wine for treating arthralgia and preparation method thereof | |
| CN103751502B (en) | The Chinese medicine for the treatment of acne vulgaris | |
| CN106038905A (en) | Narcotic analgesic and preparation method thereof | |
| CN105456708A (en) | Drug for treating cheilitis and preparation method thereof | |
| CN105535853A (en) | Traditional Chinese medicine composition for treating bedsores for clinical nursing | |
| CN102813854B (en) | Chinese herbal medicine paste used for treating acne | |
| CN107198763A (en) | A kind of external application Chinese medicine for preventing and treating shank vein varicose and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201201 |
|
| RJ01 | Rejection of invention patent application after publication |